http://bourse.lesechos.fr/valeurs-moyennes/valeurs-du-jour/flashs-analystes/publication-de-la-tresorerie-t1-966748.php
Hmmmm,concerning. Was unaware of the transfer of assets b/w novartis and gsk. Sounds like Transgenes trial is more advanced than the other lung cancer vaccines, but still a worry. We'll find out by months end either way. Should do nice things for Virax, if only a launching pad for the co-x-gene platform. Fingers crossed novartis takes up the option.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
-0.001(3.57%) |
Mkt cap ! $46.40M | |||
| Open | High | Low | Value | Volume |
| 2.8¢ | 2.8¢ | 2.7¢ | $2.318K | 83.08K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 504704 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 2243930 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| VHL (ASX) Chart |